Task: Answer Verification
Input (English): Question: Does spironolactone prevent acute mountain sickness : a prospective , double-blind , randomized , placebo-controlled trial by SPACE Trial Group ( spironolactone and acetazolamide trial in the prevention of acute mountain sickness group )?
Answer: Spironolactone (50 mg BID) was ineffective in comparison to acetazolamide (250 mg BID) in the prevention of AMS in partially acclimatized western trekkers ascending to 5000 m in the Nepali Himalaya.
Output (English): no